| NCT ID | NCT02362685 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Brest |
| Condition | Metabolic Myopathies |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2008-09 |
| Primary Completion | 2027-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2008-09 with a primary completion date of 2027-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Exertional symptoms are the hallmarks of metabolic myopathies, supporting the concept of using functional tests when this diagnosis is suspected. Exercise increases the concentration of muscle metabolites in the venous blood supply (e.g. lactate, pyruvate, and ammonia) especially during recovery. The purpose of this study is to compare the results of exercise testing with to the data from muscle biopsy or genetic analysis.
Eligibility Criteria
Inclusion Criteria: * Referred to the Physiology Department of Brest Hospital for a metabolic exercise test * Ability to provide informed consent Exclusion Criteria: * Contraindication(s) to perform cardiopulmonary exercise testing (ATS/ACCP statement on cardiopulmonary exercise testing, Am J respi Care Med 167: 211-77, 2003) * Pregnancy or unknown pregnancy status.
Contact & Investigator
Fabrice Rannou, MD, PhD
PRINCIPAL INVESTIGATOR
CHRU BREST
Frequently Asked Questions
Who can join the NCT02362685 clinical trial?
This trial is open to participants of all sexes, aged 5 Years or older, studying Metabolic Myopathies. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02362685 currently recruiting?
Yes, NCT02362685 is actively recruiting participants. Contact the research team at fabrice.rannou@chu-brest.fr for enrollment information.
Where is the NCT02362685 trial being conducted?
This trial is being conducted at Brest, France.
Who is sponsoring the NCT02362685 clinical trial?
NCT02362685 is sponsored by University Hospital, Brest. The principal investigator is Fabrice Rannou, MD, PhD at CHRU BREST. The trial plans to enroll 1,000 participants.